Search Results - sophie+deng

3 Results

Sort By:

2022-153: In Vivo Biomarkers of Human Limbal Stem Cell Function

SUMMARY: UCLA researchers in the Department of Ophthalmology have identified novel in vivo biomarkers of limbal stem cell function to accurately diagnose and stage limbal stem cell deficiency. BACKGROUND: The cornea, which is the main part of the eye that is responsible for the production of clear vision, is protected from microbes and fluids by the...

Published: 9/5/2023 | Inventor(s): Sophie Deng

Keywords(s):

Category(s): Diagnostic Markers, Therapeutics > Ophthalmology

Stem Cell-Derived Exosomes for the Treatment of Corneal Scarring (UCLA Case No. 2017-838)

UCLA researchers in the Department of Ophthalmology have developed a novel method to heal corneal scarring using exosomes from immortalized corneal stem cells.BACKGROUNDCorneal stromal scarring is the leading cause of corneal blindness, the second most common type of blindness globally. The current options to restore vision are corneal transplantation...

Published: 2/14/2024 | Inventor(s): Sophie Deng, James Funderburgh

Keywords(s): iPS/stem cells, Life Science Research Tools, Medical Devices and Materials, Ophthalmology

Category(s): Life Science Research Tools, Medical Devices, Therapeutics > Ophthalmology, Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells

2017-431 XENOBIOTIC-FREE CULTURE SYSTEM TO EXPAND HUMAN LIMBAL STEM CELLS

Xenobiotic-Free Culture System To Expand Human Limbal Stem CellsSUMMARYUCLA researchers in the Departments of Opthalmology have developed a xenobiotic-free manufacturing process to produce transplantable human limbal stem cells for use in treating limbal stem cell deficiency.BACKGROUNDLimbal stem cell deficiency (LSCD) is a disorder characterized by...

Published: 2/16/2024 | Inventor(s): Sophie Deng, Sheyla Gonzalez

Keywords(s):

Category(s): Life Science Research Tools, Therapeutics > Stem Cells And Regenerative Medicine > Ips Stem Cells